Graham Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.77M Sell
141,968
-8,942
-6% -$177K 0.05% 267
2026
Q1
$2.9M Buy
150,910
+107,911
+251% +$2.13M 0.07% 207
2025
Q4
$814K Sell
42,999
-114,595
-73% -$2.12M 0.02% 445
2025
Q3
$2.94M Buy
157,594
+33,379
+27% +$623K 0.05% 170
2025
Q2
$2.29M Sell
124,215
-152,329
-55% -$2.7M 0.03% 331
2025
Q1
$4.83M Buy
276,544
+75,893
+38% +$1.28M 0.08% 141
2024
Q4
$3.48M Buy
200,651
+102,812
+105% +$1.88M 0.05% 186
2024
Q3
$1.82M Sell
97,839
-59,492
-38% -$1M 0.03% 300
2024
Q2
$2.42M Buy
+157,331
New +$2.25M 0.05% 209
2023
Q4
– Sell
-99,830
Closed -$1.39M – 1295
2023
Q3
$1.39M Buy
+99,830
New +$1.28M 0.03% 273
2022
Q4
– Sell
-54,343
Closed -$712K – 1309
2022
Q3
$712K Buy
+54,343
New +$803K 0.03% 623

Other funds holding SBRA

Graham Capital Management's SBRA Position: Q2 2026 in Review

Graham Capital Management reduced its Sabra Healthcare REIT (SBRA) stake by 5.9% in Q2 2026, selling an estimated $177K and leaving 141,968 shares worth $2.77M. The position accounts for 0.05% of the portfolio, ranked #267.

Graham Capital Management first reported a position in SBRA in Q3 2022 and has held it in 11 quarters since. The position peaked at $4.83M in Q1 2025. 466 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Graham Capital Management held 141,968 shares of Sabra Healthcare REIT worth $2.77M as of Q2 2026.
  • Graham Capital Management sold 8,942 Sabra Healthcare REIT shares in Q2 2026, an estimated $177K.
  • Sabra Healthcare REIT made up 0.05% of Graham Capital Management's portfolio in Q2 2026, its #267 holding.
  • Graham Capital Management first reported a position in Sabra Healthcare REIT in Q3 2022 and has held it in 11 quarters since.
  • Graham Capital Management's Sabra Healthcare REIT position peaked at $4.83M in Q1 2025.
  • 466 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.